Appia Bio: Funding, Investors & Team (Sep 2026)
Appia Bio is an early-stage biotechnology company based in Los Angeles, California. Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).
Appia Bio has raised $52.0M across 1 funding round on record, the most recent an undisclosed round of $52.0M announced in May 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Appia Bio Company Profile and Key Stats
Latest funding round on record: May 2021.
Appia Bio Funding Rounds
Appia Bio Founders and Leadership Team
No contact details are on record for this team yet.
Appia Bio Funding Compared to Other Biotechnology Startups
Appia Bio's latest round of $52.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Appia Bio in Biotechnology and Los Angeles
Companies Similar to Appia Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Appia Bio Funding FAQs
What does Appia Bio do?
Appia Bio is an early-stage biotechnology company based in Los Angeles, California. Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).
How much funding has Appia Bio raised?
Appia Bio has raised $52.0M across 1 round on record. The most recent is an undisclosed round of $52.0M announced in May 2021.
When did Appia Bio last raise funding?
Appia Bio's most recent funding round on record is an undisclosed round of $52.0M, announced in May 2021.
Who is the CEO of Appia Bio?
JeenJoo Kang is listed as CEO at Appia Bio.
Where is Appia Bio headquartered?
Appia Bio is based in Los Angeles, California, United States.
How many employees does Appia Bio have?
Appia Bio is in the 11-50 employee band.
How does Appia Bio's funding compare to other Biotechnology startups?
Appia Bio's latest round of $52.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Appia Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Appia Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.